A detailed history of Twinbeech Capital LP transactions in Twist Bioscience Corp stock. As of the latest transaction made, Twinbeech Capital LP holds 28,966 shares of TWST stock, worth $1.22 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
28,966
Holding current value
$1.22 Million
% of portfolio
0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$36.72 - $58.88 $1.06 Million - $1.71 Million
28,966 New
28,966 $1.31 Million
Q1 2024

May 15, 2024

BUY
$32.28 - $41.5 $1.32 Million - $1.69 Million
40,750 New
40,750 $1.4 Million
Q3 2023

Nov 14, 2023

BUY
$18.62 - $26.57 $622,634 - $888,474
33,439 New
33,439 $677,000
Q1 2023

May 15, 2023

BUY
$14.6 - $30.9 $1.98 Million - $4.19 Million
135,485 New
135,485 $2.04 Million
Q1 2021

May 17, 2021

SELL
$105.48 - $207.97 $392,385 - $773,648
-3,720 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$76.64 - $167.89 $285,100 - $624,550
3,720 New
3,720 $526,000

Others Institutions Holding TWST

About Twist Bioscience Corp


  • Ticker TWST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 56,363,500
  • Market Cap $2.38B
  • Description
  • Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...
More about TWST
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.